A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaı̈ve patients with metastatic or locally advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaı̈ve patients with metastatic or locally advanced non-small cell lung cancer

Published:2003-07 Issue:7 Volume:97 Page:796-803
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Ho James C.M.,Tan E.H.,Leong S.S.,Wang C.H.,Sun Y.,Li R.,Wahid M.I.A.,Jusuf A.,Liao M.,Guan Z.,Handoyo P.,Huang J.S.,Chan V.,Luna G.,Tsang K.W.T.,Lam W.K.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference32 articles.

1. Chemotherapy for advanced (stage III B and stage IV) non-small cell lung cancer;Lam;Respirology,1998

2. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: meta-analysis using updated data in individual patients from 52 randomized clinical trials. Br Med J 1995;311:899–909.

3. Evolution of cisplatin-based chemotherapy in non-small cell lung cancer. A historical perspective and the Eastern Cooperative Oncology Group experience;Johnson;Chest,2000

4. New combinations in the treatment of lung cancer. A time for optimism;Bunn;Chest,2000

5. Docetaxel;Trudeau;Can J Oncol,1996

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2017-12

2. Docetaxel and Cisplatin Regimen for Non-Small-Cell Lung Cancer;Hospital Pharmacy;2013-07

3. A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan;Lung Cancer;2007-06

4. Docetaxel and Cisplatin (DP) Regimen for Solid Tumors;Hospital Pharmacy;2006-11

5. Lung cancer;Cancer Chemotherapy and Biological Response Modifiers Annual;2005